Team DoctorNDTV | Wednesday December 19, 2001
Malaria vaccine development has been very difficult, partly because of the technical challenges involved, the parasite's complexity and how it evades the immune system. Recently, a new vaccine, RTS,S/AS02, has been developed by GlaxoSmithKline Biologicals. The vaccine prevents the malarial parasite from infecting red blood cells.
Malaria is a par...
doctor.ndtv.com